StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
KREN.JK$15.00-6.25%
Fair $15.00+0.0%

KREN.JK

PT Quantum Clovera Investama Tbk

Financial Services / Asset ManagementJakarta

$15.00

-1.00 (-6.25%)

Fairly Valued+0.0%Fair Value $15.00Fund rank 22/100 · Data gapFallback financials|
SA 11/F
F-Score: 0/9
Declining Revenue

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 0.0/100

Data gap 22/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 15/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

11/100

F

Piotroski

0/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: unknownPeriods: 5Warnings: 1unknown: 5
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified. Revenue has declined for 3 consecutive years
Thesis & Journal · KREN.JKLocal privado en este navegador · PT Quantum Clovera Investama Tbk
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$273.1B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

N/A

•

Gross Margin

N/A

•

Debt/Equity

N/A

•
52-Week Range$15
$8$37

TradingView lightweight chart

KREN.JK price, volumen y niveles de valoración

Último $15.00Periodo +120.1%
Fair value: $15.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2025 · 4 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

—

FCF margin

—

FCF / Net income

—

Latest source

Provider fallback

Margin decomposition

Último año: revenue $4.59T · net income — · FCF —

2021-FY → 2025-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

—— pts

FCF margin

—— pts
MetricTTM
2025
2024
2023
2022
2021
Income Statement
Revenue$4591.04B$4591.04B$7105.98B$11661.51B$12266.68B—
Net Income——$-33.15B$-55.73B$-98.87B$-458.93B
EPS-7.12-7.12-1.82-3.06-5.43—
Net Margin——-0.5%-0.5%-0.8%—
Balance Sheet
Debt/Equity——2.101.560.360.27
Current Ratio1.681.68————
Cash Flow
Free Cash Flow——$-92.66B$27.95B$-25.74B$120.93B
Returns
ROE——-23.0%-31.4%-29.7%-78.8%
Valuation
P/B——1.015.132.732.78
Growth & Yield
Revenue Growth-35.4%-35.4%-39.1%-4.9%——
EPS Growth-291.3%-291.3%40.5%43.6%——

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +50.0%

Total return

+50.0%

Start / end P/E

n/dx → n/dx

EPS bridge

-1.82 → -7.12

Residual

+50.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+50.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.